Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
0.00
0.00 (0.00%)
Apr 9, 2026, 9:32 AM EDT - Market open
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 86 employees as of December 31, 2025. The number of employees increased by 16 or 22.86% compared to the previous year.
Employees
86
Change (1Y)
16
Growth (1Y)
22.86%
Revenue / Employee
$389,326
Profits / Employee
-$615,756
Market Cap
249.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 16 | 22.86% |
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | 11 | 24.44% |
| Sep 30, 2022 | 45 | - | - |
| Jun 30, 2022 | 42 | - | - |
| Mar 31, 2022 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Coherus Oncology | 147 |
| Arcturus Therapeutics Holdings | 111 |
| SAB Biotherapeutics | 86 |
| Keros Therapeutics | 78 |
| Cybin | 50 |
| Camp4 Therapeutics | 48 |
| ALX Oncology Holdings | 43 |
OBIO News
- 4 weeks ago - Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 5 weeks ago - Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT - GlobeNewsWire
- 7 weeks ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
- 7 weeks ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - GlobeNewsWire
- 4 months ago - Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting - GlobeNewsWire
- 5 months ago - Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
- 5 months ago - Orchestra BioMed to Host Business Update Call on November 12, 2025 - GlobeNewsWire